Dr. Phil Connelly is a Staff Scientist in the Keenan Research Centre for Biomedical Science of St. Michael’s Hospital. He has a primary academic appointment in the Department of Medicine at the University of Toronto, as well as a graduate appointment in the Department of Laboratory Medicine and Pathobiology. Dr. Connelly’s current basic research is focused on the metabolism of hydroxy fatty aldehydes. The chemistry of this system involves glutathione and the products are readily exported from the cells to undergo further metabolism. The products are known to be proinflammatory and, we hypothesize, atherothrombotic.
Collaborative research on patient populations is focused on renal transplant recipients, women with gestational diabetes and subjects with pre-diabetes.